- Testing Types
- USP Compendial Monograph Testing
Terms and Conditions
Sample Submission Form
Overview
USP Compendial Monographs define official quality standards for pharmaceutical ingredients, finished drug products, excipients, dietary supplements, and other healthcare materials. At PLS Analytical, these monographs guide the evaluation of identity, strength, purity, performance, and other critical quality attributes to support compliance with recognized pharmacopeial requirements.
PLS Analytical performs USP compendial monograph testing using official USP methods and acceptance criteria to verify product quality and compliance. Depending on the applicable monograph, studies may include identification, assay, impurity evaluation, dissolution, content uniformity, microbial testing, physical characterization, and other product-specific requirements. Testing supports raw materials, APIs, excipients, in-process materials, finished products, stability studies, and commercial release programs.
Meeting USP monograph requirements is essential for demonstrating product quality, supporting regulatory compliance, and maintaining consistency throughout the pharmaceutical lifecycle. Compendial testing helps manufacturers verify that products meet established quality standards while reducing the risk of batch rejection, regulatory observations, and supply chain disruptions.
PLS Analytical delivers scientifically rigorous compendial testing aligned with USP standards, helping manufacturers generate reliable, submission-ready data that supports quality systems, regulatory inspections, commercial manufacturing, and global market requirements.
Testing Services
PLS Analytical performs USP compendial monograph testing to support product development, raw material qualification, release testing, stability programs, and regulatory compliance activities across pharmaceutical and healthcare products.
1. Raw Material (Excipients & API) Compendial Testing
1. Raw Material (Excipients & API) Compendial Testing
Raw material compendial testing evaluates active pharmaceutical ingredients and excipients against applicable USP monograph requirements. Scientifically robust data supports API qualification, excipient testing, incoming material release, and pharmacopeial compliance.
2. Finished Product Compendial Testing
2. Finished Product Compendial Testing
Finished product compendial testing evaluates pharmaceutical products against USP monograph specifications and acceptance criteria. Scientifically robust data supports commercial batch release, product qualification, quality control programs, and regulatory compliance.
3. Stability & Lifecycle Compendial Testing
3. Stability & Lifecycle Compendial Testing
Stability and lifecycle compendial testing evaluates product quality throughout defined stability programs using applicable USP monograph methods. Scientifically robust data supports stability programs, shelf-life determination, lifecycle management, and regulatory submissions.
Advantages
USP compendial testing provides standardized quality data that supports product release, regulatory compliance, and lifecycle quality management.
Standardized Quality Assessment
Testing is performed according to recognized pharmacopeial procedures, ensuring consistency and comparability across products, facilities, and quality programs.
Reliable Release Decisions
Compendial testing generates objective quality data that supports batch release, material qualification, and routine quality control activities.
Reduced Regulatory Risk
Demonstrating compliance with official USP standards helps strengthen inspection readiness, support regulatory submissions, and reduce compliance-related observations.
Regulatory Compliance
USP compendial monograph testing supports compliance with recognized pharmacopeial standards referenced throughout pharmaceutical quality systems and regulatory frameworks. Testing documentation can support product registration activities, audits, inspections, release programs, and ongoing quality management.
